author-photo

Hans-Peter Guler

University of Wisconsin-Madison

7

Papers

422

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Pharmacokinetics and antiviral activity of PHX1766, a novel HCV protease inhibitor, using an accelerated Phase I study design

2011 Antiviral Therapy
Show All
- Source
- Cite
- Save
Citations (10)
Evaluation of the potential for pharmacokinetic and pharmacodynamic interactions between dutogliptin, a novel DPP4 inhibitor, and metformin, in type 2 diabetic patients.

2010 Current Medical Research and Opinion
Show All
- Source
- Cite
- Save
Citations (4)
Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12-week, double-blind, randomized, placebo-controlled, multicentre trial.

2010 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (30)
The dipeptidyl peptidase-4 inhibitor PHX1149 improves blood glucose control in patients with type 2 diabetes mellitus

2008 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (25)
Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: A randomized, dose-ranging study

2003 JAMA
Show All
- Source
- Cite
- Save
Citations (186)
Adverse Effects of Recombinant Human Insulin-like Growth Factor I in Obese Insulin-Resistant Type II Diabetic Patients

1994 Diabetes
Show All
- Source
- Cite
- Save
Citations (115)
Short-term effects of recombinant human insulin-like growth factor I on metabolic control of patients with type II diabetes mellitus.

1993 The Journal of Clinical Endocrinology and Metabolism
Show All
- Source
- Cite
- Save
Citations (52)